Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Kelvin P Lee

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Clinical and Tissue Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Robert Zygmunt Orlowski

Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma

Multiple myeloma and immunoproliferative diseases

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Steven M Lipkin

Whole Genome Sequencing to Discover Familial Myeloma Risk Genes

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Colorectum

Jonathan Hofmann

Pooled Investigation of Circulating Adiponectin and Multiple Myeloma and Immunoproliferative Diseases in the NCI Cohort Consortium

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology